Foutmelding

Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in include_once() (line 2 of D:\web\EEN2017\cms\sites\enterpriseeuropenetwork.nl\settings.php).

Biotech, diagnostic equipment manufacturers sought for Eurostars project to develop high volume, rapid, bovine tuberculosis tests.

REQUEST from United Kingdom, reference: RDUK20180207001, valid from 07-02-2018 untill 16-02-2018

Research & Development
  • Start date:
    7 februari 2018 (3 weken geleden)
  • End date:
    16 februari 2018 (2 weken geleden)
  • Summary:
    A UK biotech SME has developed a unique, rapid diagnostic test for live bacteria that cause bovine tuberculosis (bTB) not just in cattle but many other animal species. It should save significant costs and unnecessary culling in global meat and dairy industries. Just launching the product in single unit test form the company seeks biotech manufacturing partners in the Netherlands or Denmark to join a development project to scale-up the test in a Eurostars funded development project.
  • Description:
    The incidence of bovine tuberculosis (bTB) represents a real cost to meat and dairy industries across the world. Although it appears to have been eradicated in most of Europe, pockets of the disease still stubbornly persist in wildlife in countries such as the UK, USA and Canada posing a risk to cattle, sheep and goat herds requiring stringent control measures in all countries.

    Diagnostic testing for the disease is a critical factor in these measures but current skin tests based on an animal’s immune response take 3 days to produce results and, more worryingly, such tests are known to miss about 20% of the animals. Other, more accurate tests require many days, up to 3 months, to produce meaningful results meaning that major costs are incurred as the disease spreads through whole herds before it is detected.

    A UK biotech SME has successfully developed a unique test directly detecting live bacteria in blood or milk. It is fast and highly sensitive with the potential to produce results within 6 hours.

    The company is about to launch diagnostic products based on this technology which it will manufacture as single test kits. Significant international interest from governments, regulatory authorities and primary meat and dairy producers is already being shown which indicates a requirement to scale this test to cope with high volume demands. The UK company therefore wishes to work with a biotech diagnostic equipment manufacturer to develop a high volume test system utilising this technology.

    It is intended to make an application for Eurostars support by the closing date of 1st March 2018, so the UK company seeks a biotech diagnostics manufacturing partner in either the Netherlands or Denmark. The partner should be able to introduce ideas, processes and automation technologies that would enable testing to be scaled-up from the existing single tube test to the equivalent of a 96 plate array. Expressions of interest are required by Friday 16th February 2018.
Partner Sought
  • Type of Partnership Considered:
    Research cooperation agreement
  • Technical Specification or Expertise Sought:

    From their experience and expertise, the partner should be able to introduce ideas, processes and automation technologies that would enable the bio-technology to be scaled-up from the existing single tube test to the equivalent of a 96 plate array test.

    The partner needs to be a company engaged in the manufacture of medical or veterinary diagnostic equipment. They need to be located in either the Netherlands or Denmark and keen to participate in a Eurostars supported development project. From their experience and expertise, the partner should be able to introduce ideas, processes and automation technologies that would enable the bio-technology to be scaled-up from the existing single tube test to the equivalent of a 96 plate array test.

    SME 11-50,SME <10,251-500,SME 51-250

Organisation
  • Development stage:
    Proposal under development
  • IPR Status:
    Secret Know-how,Patent(s) applied for but not yet granted,Exclusive Rights
  • Market keywords:
    Microbiology
    Diagnostic services
    Molecular diagnosis
    Agriculture, Forestry, Fishing, Animal Husbandry & Related Products
  • Technology keywords:
    Diagnostics, Diagnosis
    Cellular and Molecular Biology
    Microbiology
    Micro- and Nanotechnology related to Biological sciences
    Micro- and Nanotechnology related to agrofood
  • NACE keywords:
    Support activities for animal production
    Research and experimental development on biotechnology
  • Advantages and Innovations:
    • Fast response with results available in 6 – 8 hours (i.e. same day) compared to between 1 – 3 months for the current “gold standard” tests. This ensures early detection of infection thus enabling far more effective treatment and control.

    • Sensitivity and specificity better than current “gold standard” tests.

    • Simple to operate and cost effective compared to current “gold standard” tests, offering attractive sales margins.

    • Technology has been developed from university research and has been scientifically peer reviewed ensuring its validity.

    • The core technology is patent protected ensuring any collaboration partner can enjoy competitive advantage in their markets.
Client
  • Type and Size of Organisation:
    Industry SME <= 10
  • Already Engaged in Trans-National Cooperation
    Ja
  • Year Established:
    2014
  • Turnover:
    <1M
  • Country of origin:
    United Kingdom
  • Languages spoken
    • English
    • French
    • Spanish
    • Italian
Program
Afbeeldingen
Images